Lexicon Pharmaceuticals, Inc. (LXRX) is now among the bigger bargains in its industry.
Within the last year the price ranged from $1.13 – 8.4 and there is a wide opportunity to get in. Its next earnings report will be released on Mar 11, 2020.
move, based on 10 analysts offering 12 month price targets for Illumina in the last 3 months. The average price target is $342.50 with a high forecast of $380.00 and a low forecast of $300.00. The average price target represents a 6.90% increase from the last price of $320.39.
Analysts like Dan Leonard from Wells Fargo believe that we could see stock price minimum $300.00.
Another prominent analyst, William Quirk of Piper Sandler rates ILMN as a Buy. The rating was made just Last month.
Illumina, Inc.(ILMN) Recent News Reports
On average 10.0 articles are written each week about ILMN but this week 11 articles were written and they were 68% Bullish and 32% Bearish.
Illumina, Inc. Target Levels
The market experts are predicting that ILMN is a Moderate Buy. Some other stocks to consider in this sector are: